Li, F., Miao, L., Xue, T., Qin, H., Mondal, S., Thompson, P. R., . . . Zhang, X. (2019). Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells. J Exp Clin Cancer Res.
Styl ChicagoLi, Fujun, Lixia Miao, Teng Xue, Hao Qin, Santanu Mondal, Paul R. Thompson, Scott A. Coonrod, Xiaoqiu Liu, a Xuesen Zhang. "Inhibiting PAD2 Enhances the Anti-tumor Effect of Docetaxel in Tamoxifen-resistant Breast Cancer Cells." J Exp Clin Cancer Res 2019.
Citace podle MLALi, Fujun, et al. "Inhibiting PAD2 Enhances the Anti-tumor Effect of Docetaxel in Tamoxifen-resistant Breast Cancer Cells." J Exp Clin Cancer Res 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..